G337

PDF page 455 / J41

DIAGNOSTIC AND THERAPEUTIC PROCEDURES
 ENDOCRINOLOGY AND METABOLISM
                                                                                                Fee
+ G493 ACTH test - single or multiple, per injection ...........................                 6.25
+ G337 Antidiuretic hormone response test including the 8 hour water
         deprivation test ...................................................................   16.95
+ G338 Clonidine suppression test (for the investigation of
         pheochromocytoma) - with physician present - includes
         venipunctures .....................................................................    24.90
    Glucagon test
+ G494 - (Type A) for carbohydrate response ...................................                 10.20
+ G495 - (Type B) for hypertension, pheochromocytoma and
         insulinoma provocative test (including cold pressor test) ...                          42.30
  G358 Growth hormone exercise stimulation test with physician
          present (includes venipunctures) .......................................              24.90
+ G340 Histamine test to include a control cold pressor test ..............                     45.45
+ G341 Hypertonic saline infusion test ................................................         16.95
+ G497 Insulin hypoglycemia pituitary function test with or without TRH
          and LHRH alone or in combination ....................................                 49.80
+ G318 Insertion of non-biodegradable long-acting subcutaneous
          medication implant .............................................................      42.00
          Payment rules:
          1. G318 is not eligible for payment when provided by injection.
          2. G318 is only eligible for payment when the service is personally rendered by the physician
          [Commentary:
          1.Nexplanon is an example of non-biodegradable long-acting subcutaneous medication
            implant.
          2.Zoladex is an example of a biodegradable medication implant for which G318 is not eligible
            for payment.
          3.See Z114 and Z115 for removal of long-acting subcutaneous medication implant.
          4.For injections that do not meet the above criteria for G318, see Injections listings on page
            J54 of the Schedule.]
Diabetes monthly management
The provision to a patient, patient's relative(s), patient's representative or other caregiver(s) of medical
advice, direction or information by telephone or otherwise, in which a change in the frequency or dose
of insulin therapy is initiated regarding a patient treated with insulin injections (2 or more daily) or
insulin by pump (a "contact").

Master, record 2049. Record Layout PDF, page 1.

G33720250401999999990000016950000000000000000000000000000000000000000000000

Auxiliary master fields are preserved as raw scaled values. The linked layout calls them zero-filled, but this edition contains non-zero values. They are not presented as final dollar fees or PDF units.